Cronos Historical Balance Sheet

CRON Stock

USD 1.87 0.08 4.47%

Trend analysis of Cronos Group balance sheet accounts such as Other Current Liab of 55.5 M, Total Current Liabilities of 73.5 M or Total Stockholder Equity of 767.5 M provides information on Cronos' total assets, liabilities, and equity, which is the actual value of Cronos Group to its prevalent stockholders. By breaking down trends over time using Cronos balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Cronos Group latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Cronos Group is a good buy for the upcoming year.

Cronos Inventory

24.36 Million

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cronos Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

About Cronos Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Cronos Group at a specified time, usually calculated after every quarter, six months, or one year. Cronos Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Cronos and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Cronos currently owns. An asset can also be divided into two categories, current and non-current.

Cronos Balance Sheet Chart

At this time, Cronos' Capital Lease Obligations is very stable compared to the past year. As of the 24th of March 2025, Deferred Long Term Liabilities is likely to grow to about 97.8 K, while Total Assets are likely to drop about 848.6 M.

Total Assets Total Current Liabilities Total Stockholder Equity Accounts Payable Non Current Liabilities Total

Add Fundamental

Total Assets

Total assets refers to the total amount of Cronos assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Cronos Group books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Cronos balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Cronos Group are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Accounts Payable

An accounting item on the balance sheet that represents Cronos obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Cronos Group are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Most accounts from Cronos' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Cronos Group current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cronos Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

	2022	2023	2024	2025 (projected)
Total Stockholder Equity	1.1B	1.1B	1.1B	767.5M
Total Current Liabilities	68.1M	41.4M	49.7M	73.5M

Total Stockholder Equity Total Current Liabilities

Cronos balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Long Term Debt Total	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Non Currrent Assets Other	Other Assets	Good Will	Common Stock Total Equity	Capital Surpluse
Total Assets		0.8	0.85	1.0	-0.98	0.98	0.9	0.99	0.97	1.0	0.83	0.9	0.87	0.81	0.25	0.86	1.0	0.47	0.81	0.98	0.85	0.7	0.76	0.77	0.88	0.85
Other Current Liab	0.8		0.99	0.76	-0.74	0.88	0.88	0.76	0.86	0.79	0.35	0.51	0.72	0.48	0.04	0.99	0.78	0.39	0.58	0.68	0.76	0.58	0.64	0.97	0.51	0.45
Total Current Liabilities	0.85	0.99		0.81	-0.79	0.9	0.92	0.8	0.9	0.83	0.42	0.59	0.75	0.57	0.07	1.0	0.82	0.45	0.64	0.73	0.8	0.63	0.68	0.95	0.58	0.52
Total Stockholder Equity	1.0	0.76	0.81		-0.98	0.97	0.88	0.99	0.96	1.0	0.86	0.91	0.87	0.82	0.26	0.82	1.0	0.46	0.81	0.99	0.83	0.69	0.76	0.73	0.9	0.87
Net Debt	-0.98	-0.74	-0.79	-0.98		-0.95	-0.86	-0.99	-0.93	-0.98	-0.85	-0.9	-0.84	-0.82	-0.42	-0.8	-0.98	-0.37	-0.79	-0.98	-0.81	-0.62	-0.68	-0.72	-0.94	-0.91
Retained Earnings	0.98	0.88	0.9	0.97	-0.95		0.89	0.97	0.98	0.98	0.73	0.81	0.88	0.74	0.19	0.91	0.97	0.44	0.76	0.93	0.83	0.68	0.81	0.85	0.8	0.77
Accounts Payable	0.9	0.88	0.92	0.88	-0.86	0.89		0.88	0.91	0.89	0.62	0.8	0.81	0.77	0.27	0.92	0.89	0.54	0.78	0.84	0.9	0.65	0.57	0.85	0.76	0.7
Cash	0.99	0.76	0.8	0.99	-0.99	0.97	0.88		0.94	1.0	0.86	0.91	0.85	0.83	0.31	0.81	1.0	0.41	0.79	0.99	0.82	0.65	0.73	0.73	0.9	0.87
Non Current Assets Total	0.97	0.86	0.9	0.96	-0.93	0.98	0.91	0.94		0.95	0.73	0.84	0.92	0.81	0.19	0.91	0.95	0.6	0.84	0.92	0.92	0.7	0.81	0.84	0.81	0.78
Cash And Short Term Investments	1.0	0.79	0.83	1.0	-0.98	0.98	0.89	1.0	0.95		0.84	0.89	0.85	0.79	0.26	0.84	1.0	0.41	0.78	0.98	0.81	0.69	0.74	0.75	0.89	0.85
Net Receivables	0.83	0.35	0.42	0.86	-0.85	0.73	0.62	0.86	0.73	0.84		0.95	0.68	0.82	0.36	0.44	0.85	0.35	0.73	0.92	0.63	0.59	0.54	0.32	0.92	0.93
Common Stock Shares Outstanding	0.9	0.51	0.59	0.91	-0.9	0.81	0.8	0.91	0.84	0.89	0.95		0.81	0.91	0.37	0.61	0.9	0.5	0.86	0.94	0.79	0.69	0.58	0.49	0.94	0.92
Non Current Liabilities Total	0.87	0.72	0.75	0.87	-0.84	0.88	0.81	0.85	0.92	0.85	0.68	0.81		0.78	0.22	0.76	0.85	0.64	0.87	0.84	0.87	0.61	0.78	0.72	0.74	0.72
Other Current Assets	0.81	0.48	0.57	0.82	-0.82	0.74	0.77	0.83	0.81	0.79	0.82	0.91	0.78		0.44	0.59	0.81	0.6	0.85	0.85	0.86	0.59	0.59	0.51	0.86	0.86
Other Stockholder Equity	0.25	0.04	0.07	0.26	-0.42	0.19	0.27	0.31	0.19	0.26	0.36	0.37	0.22	0.44		0.07	0.27	-0.14	0.28	0.33	0.33	-0.05	-0.21	0.15	0.59	0.59
Total Liab	0.86	0.99	1.0	0.82	-0.8	0.91	0.92	0.81	0.91	0.84	0.44	0.61	0.76	0.59	0.07		0.83	0.46	0.65	0.74	0.81	0.64	0.69	0.95	0.6	0.53
Total Current Assets	1.0	0.78	0.82	1.0	-0.98	0.97	0.89	1.0	0.95	1.0	0.85	0.9	0.85	0.81	0.27	0.83		0.42	0.79	0.99	0.81	0.69	0.74	0.74	0.89	0.86
Short Long Term Debt Total	0.47	0.39	0.45	0.46	-0.37	0.44	0.54	0.41	0.6	0.41	0.35	0.5	0.64	0.6	-0.14	0.46	0.42		0.73	0.42	0.72	0.3	0.54	0.35	0.35	0.37
Other Liab	0.81	0.58	0.64	0.81	-0.79	0.76	0.78	0.79	0.84	0.78	0.73	0.86	0.87	0.85	0.28	0.65	0.79	0.73		0.81	0.86	0.57	0.61	0.56	0.79	0.77
Net Tangible Assets	0.98	0.68	0.73	0.99	-0.98	0.93	0.84	0.99	0.92	0.98	0.92	0.94	0.84	0.85	0.33	0.74	0.99	0.42	0.81		0.81	0.65	0.7	0.65	0.93	0.91
Property Plant And Equipment Net	0.85	0.76	0.8	0.83	-0.81	0.83	0.9	0.82	0.92	0.81	0.63	0.79	0.87	0.86	0.33	0.81	0.81	0.72	0.86	0.81		0.6	0.61	0.8	0.75	0.74
Non Currrent Assets Other	0.7	0.58	0.63	0.69	-0.62	0.68	0.65	0.65	0.7	0.69	0.59	0.69	0.61	0.59	-0.05	0.64	0.69	0.3	0.57	0.65	0.6		0.58	0.57	0.56	0.53
Other Assets	0.76	0.64	0.68	0.76	-0.68	0.81	0.57	0.73	0.81	0.74	0.54	0.58	0.78	0.59	-0.21	0.69	0.74	0.54	0.61	0.7	0.61	0.58		0.6	0.5	0.5
Good Will	0.77	0.97	0.95	0.73	-0.72	0.85	0.85	0.73	0.84	0.75	0.32	0.49	0.72	0.51	0.15	0.95	0.74	0.35	0.56	0.65	0.8	0.57	0.6		0.5	0.45
Common Stock Total Equity	0.88	0.51	0.58	0.9	-0.94	0.8	0.76	0.9	0.81	0.89	0.92	0.94	0.74	0.86	0.59	0.6	0.89	0.35	0.79	0.93	0.75	0.56	0.5	0.5		0.99
Capital Surpluse	0.85	0.45	0.52	0.87	-0.91	0.77	0.7	0.87	0.78	0.85	0.93	0.92	0.72	0.86	0.59	0.53	0.86	0.37	0.77	0.91	0.74	0.53	0.5	0.45	0.99

Click cells to compare fundamentals

Cronos Account Relationship Matchups

Cronos balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	1.9B	1.4B	1.2B	1.1B	1.2B	848.6M
Other Current Liab	183.3M	37.1M	18.5M	28.2M	31.7M	55.5M
Total Current Liabilities	206.8M	54.4M	68.1M	41.4M	49.7M	73.5M
Total Stockholder Equity	1.7B	1.3B	1.1B	1.1B	1.1B	767.5M
Net Debt	(1.1B)	(877.2M)	(760.8M)	(666.7M)	(856.8M)	(813.9M)
Retained Earnings	1.1B	659.4M	490.7M	416.7M	457.7M	384.4M
Accounts Payable	19.3M	11.1M	11.2M	12.1M	17.0M	11.6M
Cash	1.1B	887.0M	764.6M	669.3M	858.8M	503.5M
Non Current Assets Total	553.5M	318.0M	252.9M	206.8M	230.2M	213.5M
Cash And Short Term Investments	1.3B	1.0B	877.7M	861.5M	858.8M	589.8M
Net Receivables	26.0M	33.3M	31.3M	35.9M	29.8M	16.8M
Common Stock Shares Outstanding	351.6M	370.4M	377.0M	381.0M	382.1M	249.4M
Liabilities And Stockholders Equity	1.9B	1.4B	1.2B	1.1B	1.2B	848.6M
Non Current Liabilities Total	10.7M	9.1M	3.9M	2.6M	5.6M	4.7M
Other Current Assets	12.3M	9.0M	13.6M	5.6M	14.4M	7.2M
Other Stockholder Equity	34.6M	32.5M	42.7M	48.4M	669.9M	703.4M
Total Liab	217.5M	63.5M	72.0M	44.0M	55.3M	78.1M
Total Current Assets	1.4B	1.1B	960.2M	933.3M	936.1M	635.1M
Short Long Term Debt Total	9.8M	9.8M	3.9M	2.6M	2.0M	1.9M
Other Liab	1.8M	2.2M	2.0M	1.4M	1.6M	1.5M
Net Tangible Assets	1.5B	1.5B	1.3B	1.1B	1.3B	683.3M
Property Plant And Equipment Net	197.4M	83.0M	62.8M	60.5M	134.6M	89.1M
Non Currrent Assets Other	87.7M	100K	72.5M	69.4M	15.5M	14.7M
Other Assets	116.7M	80.7M	72.5M	(5.8M)	(6.7M)	(6.4M)
Good Will	179.5M	1.1M	1.0M	1.1M	63.5M	46.6M
Common Stock Total Equity	165.6M	561.2M	569.3M	595.5M	684.8M	719.1M
Capital Surpluse	11.3M	23.2M	34.6M	32.5M	37.3M	39.2M
Capital Lease Obligations	9.8M	9.8M	3.9M	2.6M	2.0M	3.5M
Inventory	44.0M	32.8M	37.6M	30.5M	33.1M	24.4M
Long Term Investments	106.9M	135.2M	89.7M	54.7M	2.8M	2.7M
Property Plant And Equipment Gross	197.4M	83.0M	207.2M	200.6M	268.0M	281.4M
Accumulated Other Comprehensive Income	43.0M	49.9M	(797K)	20.7M	(63.5M)	(60.3M)
Short Term Debt	1.3M	2.7M	1.3M	994K	1.0M	2.0M
Intangible Assets	69.7M	18.1M	26.7M	21.1M	11.3M	10.7M

Pair Trading with Cronos

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cronos position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cronos will appreciate offsetting losses from the drop in the long position's value.

Moving against Cronos Stock

0.35	BMY	Bristol Myers Squibb Aggressive Push	Pair Corr
0.32	SNY	Sanofi ADR	Pair Corr

The ability to find closely correlated positions to Cronos could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cronos when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cronos - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cronos Group to buy it.

The correlation of Cronos is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cronos moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cronos Group moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Cronos can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Cronos Group offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cronos' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cronos Group Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cronos Group Stock:

How To Invest In Cronos

Details

Is Cronos Stock a good investment?

Details

What is Cronos' Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cronos. If investors know Cronos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cronos listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.144

Earnings Share

0.11

Revenue Per Share

0.308

Quarterly Revenue Growth

0.267

Return On Assets

(0.03)

The market value of Cronos Group is measured differently than its book value, which is the value of Cronos that is recorded on the company's balance sheet. Investors also form their own opinion of Cronos' value that differs from its market value or its book value, called intrinsic value, which is Cronos' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cronos' market value can be influenced by many factors that don't directly affect Cronos' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Cronos' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cronos is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cronos' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Cronos Historical Balance Sheet

Cronos Inventory

24.36 Million

About Cronos Balance Sheet Analysis

Cronos Balance Sheet Chart

Total Assets

Total Current Liabilities

Total Stockholder Equity

Accounts Payable

Cronos balance sheet Correlations

Cronos Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Cronos balance sheet Accounts

Pair Trading with Cronos

Moving against Cronos Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Total Liab	+ 1.0	Total Current Liabilities
Cash And Short Term Investments	+ 1.0	Total Stockholder Equity
Total Current Assets	+ 1.0	Total Stockholder Equity

Cash	- 0.99	Net Debt
Net Tangible Assets	- 0.98	Net Debt
Total Current Assets	- 0.98	Net Debt
Cash And Short Term Investments	- 0.98	Net Debt
Net Debt	- 0.98	Total Stockholder Equity
Net Debt	- 0.98	Total Assets